Neuronetics (STIM) interim PAO reports 19,968 Common Stock shares

Rhea-AI Filing Summary

Neuronetics, Inc. disclosed an initial statement of beneficial ownership for interim principal accounting officer Francis X. Brown III. The Form 3 shows he directly holds 19,968 shares of Common Stock as of the reported date, with no buy or sell transactions indicated.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider BROWN FRANCIS X III

Role Interim PAO

Type	Security	Shares	Price	Value
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 19,968 shares (Direct, null)

Footnotes (1)

Key Figures

Insider common shares held: 19,968 shares

1 metrics

Insider common shares held 19,968 shares Direct beneficial ownership following reported date on Form 3

Key Terms

Form 3, Common Stock, Interim PAO

3 terms

Form 3 regulatory

"Form 3 establishes the initial shareholdings of a company insider"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

Common Stock financial

"The filing reports beneficial ownership of 19,968 shares of Common Stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Interim PAO financial

"The insider is Francis X. Brown III, identified as the company’s interim PAO"

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

BROWN FRANCIS X III

(Last) (First) (Middle)

C/O NEURONETICS, INC.

3222 PHOENIXVILLE PIKE

(Street)

MALVERN PENNSYLVANIA 19355

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
05/05/2026

3. Issuer Name and Ticker or Trading Symbol
Neuronetics, Inc. [ STIM ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Interim PAO

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	19,968	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Patrick Devine, as Attorney-in-Fact	05/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does Neuronetics (STIM) disclose in this Form 3 filing?

The filing reports interim principal accounting officer Francis X. Brown III’s initial beneficial ownership in Neuronetics. It shows he directly holds 19,968 shares of Common Stock, providing a baseline for future insider transaction reports required under SEC rules.

How many Neuronetics (STIM) shares does Francis X. Brown III hold?

He is reported as directly holding 19,968 shares of Neuronetics Common Stock. This figure represents his beneficial ownership position following the reported date and serves as the starting point for any future reported changes in his holdings.

Did the Neuronetics (STIM) Form 3 show any insider buying or selling?

No, the Form 3 reflects a holding entry only, not a new transaction. It lists 19,968 Common Stock shares as owned after the reported date, without any associated purchase or sale activity being disclosed in this filing.

Who is the insider named in Neuronetics (STIM) latest Form 3?

The insider is Francis X. Brown III, identified as the company’s interim principal accounting officer. The filing reports his direct beneficial ownership of 19,968 Neuronetics Common Stock shares, establishing his position for ongoing SEC reporting requirements.

What is the significance of a Form 3 for Neuronetics (STIM) investors?

Form 3 establishes the initial shareholdings of a company insider such as an officer or director. For Neuronetics, it records Francis X. Brown III’s 19,968 Common Stock shares, creating a baseline against which any future insider trades will be reported on subsequent forms.